The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease

By Murphy J.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Revascularization treatment of stable coronary artery disease

By Magro Michael   Garg Scot   Serruys Patrick W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-Platelets in Stable Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4537-4567

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the Coronary Collateral Circulation on the Tp-e Interval and Tp-e/QT Ratio in Patients with Stable Coronary Artery Disease

By  

Annals of Noninvasive Electrocardiology, Vol. 20, Iss. 1, 2015-01 ,pp. : 53-61

Blackwell Publishing

Access to resources Recommend Favorite

Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery Disease

By Min Tao Qian   Zhu Chen Jun   Xiang Wang Xing   Hui Zhu Jun   Peng Shang Yun  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 3, 2004-05 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite